Note 15 – Segment Reporting

The Company has two operating and reporting segments (ophthalmic technology and digital assets). The accounting policies of the segment are the same as those described in the summary of significant accounting policies. The chief operating decision maker (“CODM”), who is the Company’s chief executive officer, utilizes the Company’s financial information on an aggregate basis for purposes of making operating decisions, allocating resources and assessing financial performance, as well as for making strategic operations decisions and managing the organization.

The following table summarizes the activity of the Company’s segments for the years ended December 31, 2025 and 2024:

For the Years Ended December 31,

  ​ ​ ​

2025

  ​ ​ ​

2024

Ophthalmic

Digital

Corporate/

Ophthalmic

Digital

Corporate/

  ​ ​ ​

Technology

  ​ ​ ​

Assets

  ​ ​ ​

Other

  ​ ​ ​

Total

  ​ ​ ​

Technology

  ​ ​ ​

Assets

  ​ ​ ​

Other

  ​ ​ ​

Total

Revenue:

Revenue

$

14,720

$

798,735

$

$

813,455

$

57,336

$

$

$

57,336

Less:

 

  ​

 

  ​

Cost of revenue

(48)

(303,242)

 

(303,290)

(3,927,228)

 

(3,927,228)

Gross Income (Loss)

14,672

495,493

 

510,165

(3,869,892)

 

(3,869,892)

Less:

 

  ​

 

  ​

Research and Development:

 

  ​

 

  ​

Salaries and benefits

1,099,840

 

1,099,840

6,215,323

 

6,215,323

Direct clinical and non-clinical expenses

151,180

 

151,180

3,072,416

 

3,072,416

Facilities expenses

190,182

190,182

834,406

834,406

Non-cash stock based compensation expenses

389,245

389,245

623,049

623,049

Supplies and materials

25,130

 

25,130

2,195,608

 

2,195,608

Other Expenses(1)

42,165

42,165

409,457

409,457

Depreciation expense

12,688

 

12,688

1,112,463

 

1,112,463

Realized gain - digital assets

(8,321,844)

 

(8,321,844)

 

Unrealized gain/loss - digital assets

9,030,413

 

9,030,413

 

Impairment loss - digital assets

27,188,768

 

27,188,768

 

Impairment loss - other assets

 

11,207,897

 

11,207,897

Gain on covered call option

(157,570)

 

(157,570)

 

Provision for credit losses

405,331

 

405,331

 

Reacquisition of license rights

 

4,864,600

 

4,864,600

Segment loss

1,910,430

28,145,098

 

30,055,528

30,535,219

 

30,535,219

Reconciling Items

 

 

Selling, general and administrative expense (2)

17,175,698

17,175,698

14,333,114

14,333,114

Other (income) expense, net (3)

 

(1,406,626)

(1,406,626)

(1,080,208)

 

(1,080,208)

Net Income (Loss)

$

(1,895,758)

$

(27,649,605)

$

(15,769,072)

$

(45,314,435)

$

(49,818,433)

$

$

$

(49,818,433)

(1)Other research and development expenses include outsourced engineering and IT systems used for research and development.
(2)Selling, general and administrative expenses primarily include professional fees, general and administrative compensation expenses, general strategic consulting, Nasdaq/SEC fees, insurance and facilities expenses.
(3)Other (income) expense, net includes interest income, interest expense and gain on extinguishment of liabilities.

The following table summarizes the segment assets for the years ended December 31, 2025 and 2024:

December 31, 2025

December 31, 2024

  ​ ​ ​

Ophthalmic

  ​ ​ ​

Digital

  ​ ​ ​

Corporate/

  ​ ​ ​

  ​ ​ ​

Ophthalmic

  ​ ​ ​

Digital

  ​ ​ ​

Corporate/

  ​ ​ ​

Technology

Assets

Other

Total

Technology

Assets

Other

Total

Segment Assets

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

 

  ​

Cash

$

$

$

6,443,467

$

6,443,467

$

2,121,463

$

$

$

2,121,463

Digital assets

 

 

43,872,033

 

 

43,872,033

 

 

 

 

All other assets

 

132,652

 

 

1,316,104

 

1,448,756

 

1,546,296

 

 

 

1,546,296

Total Assets

$

132,652

$

43,872,033

$

7,759,571

$

51,764,256

$

3,667,759

$

$

$

3,667,759

Historical Timeline

Fiscal YearFiled
2025Mar 30, 2026Showing above
2024Apr 15, 2025

About Segments Disclosures

Segment disclosures break a company into its reportable operating units, revealing revenue, profit, and asset allocation that consolidated financial statements obscure. Under ASC 280, segments must match how the chief operating decision maker views the business, providing a window into internal management structure and resource allocation priorities.

Key signals: compare segment margins to identify which units drive profitability and which destroy value. Watch for changes in the number of reportable segments — segment aggregation or disaggregation often coincides with strategic shifts or attempts to obscure declining performance. Intersegment elimination patterns reveal internal pricing practices. The reconciliation between segment totals and consolidated figures exposes corporate overhead allocation and unallocated items. Geographic revenue concentration highlights regulatory and currency exposure. Compare segment-level capital expenditure against segment revenue to assess where management is investing for future growth versus harvesting existing assets.